Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age70+
SponsorDr. August Wolff GmbH & Co. KG Arzneimittel
About this trial
The aim of this study is to test the protecting and caring effect of a protective balm on patients suffering from urinary and/or fecal incontinence and need incontinence care products.
Eligibility criteria
Qualifiers
Patient is capable of understanding the information given to them and providing informed consent
70 years of age and older
Patients with incontinence (fecal and/or urinary), requiring incontinence protection material
Skin type on Fitzpatrick scale: Between I to IV
Disqualifiers
Current cancer treatment such as chemotherapy, irradiation
Documented allergies to skin care and / or skin cleansing products
Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, etc. at the test area that could influence the investigation
Incontinence-associated dermatitis (IAD) stage >1a
Trial design
Treatments tested in this trial
- Protective Balm
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov